Concepedia

Shima Moradi‐Kalbolandi

SM

6

Publications

89

Citations

6

H-Index

2015

Active since

Affiliations

Biotechnology Research Center(Current)

Motamed Cancer Institute

Academic Center for Education, Culture and Research

Pasteur Institute of Iran

Tehran University of Medical Sciences

Shima Moradi‐Kalbolandi is an author at Biotechnology Research Center specializing in immunology, immunotherapy, and medicine.

ORCID

Top concepts

Publications per year

2015–2021

6

Publications

6

Development of anti-CD47 single-chain Variable Fragment Targeted Magnetic Nanoparticles for Treatment of Human Bladder Cancer

Gashin Rezaei, Mahdi Habibi‐Anbouhi, Morteza Mahmoudi et al. · Nanomedicine · 2017 · 19 citations

Evaluation the potential of recombinant anti-CD3 nanobody on immunomodulatory function

Shima Moradi‐Kalbolandi, Azadeh Sharifi-K, Behrad Darvishi et al. · Molecular Immunology · 2019 · 19 citations

, , +10

Engineered hypoxia-responding Escherichia coli carrying cardiac peptide genes, suppresses tumor growth, angiogenesis and metastasis in vivo

Mitra Samadi, Keivan Majidzadeh‐A, Malihe Salehi et al. · Journal of Biological Engineering · 2021 · 19 citations · Full text

Development of a recombinant anti-VEGFR2-EPCAM bispecific antibody to improve antiangiogenic efficiency

Khadijeh Barzaman, Mitra Samadi, Shima Moradi‐Kalbolandi et al. · Experimental Cell Research · 2021 · 12 citations

, , +8

Antigenic assessment of a recombinant human CD90 protein expressed in prokaryotic expression system

Narges Yousefi-Rad, Mohammad Ali Shokrgozar, Mahdi Behdani et al. · Protein Expression and Purification · 2015 · 10 citations

, , +12

Rows per page

1–5 of 6